Arbutus Biopharma (ABUS)
5.12
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form SC TO-I Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
August 24, 2026 8:24 AM - SEC Filing
Arbutus Biopharma launches $230M Dutch auction tender offer
August 24, 2026 7:30 AM - StreetInsider
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
August 24, 2026 7:30 AM - StreetInsider
Form SC TO-C Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
August 21, 2026 8:04 AM - SEC Filing
Form 8-K Arbutus Biopharma Corp For: Aug 21
August 21, 2026 7:53 AM - SEC Filing
Arbutus plans $230M share repurchase via Dutch auction tender offer
August 21, 2026 7:30 AM - StreetInsider
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
August 21, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: MORGAN STANLEY
August 12, 2026 3:02 PM - SEC Filing
Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
August 12, 2026 7:50 AM - StreetInsider
Form 10-Q Arbutus Biopharma Corp For: Jun 30
August 12, 2026 7:32 AM - SEC Filing
Form 8-K Arbutus Biopharma Corp For: Aug 12
August 12, 2026 7:31 AM - SEC Filing
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026 7:30 AM - StreetInsider
Form 8-K Arbutus Biopharma Corp For: Jul 15
July 16, 2026 7:31 AM - SEC Filing
Arbutus sues Pfizer and BioNTech over LNP patents in 3 countries
July 16, 2026 7:30 AM - StreetInsider
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to
July 16, 2026 7:30 AM - StreetInsider
Full Article List
